WebThe study population consisted of consecutive symptomatic, drug-refractory PAF patients presenting for catheter ablation. All patients met accepted guideline indications for catheter ablation. 18 Ablations were performed with the THERMOCOOL SMARTTOUCH ® Catheter (ST) (Biosense Webster, Inc., Irvine, CA, USA) and CARTO VISITAG ™ Module ... WebApr 10, 2024 · We aimed to observe the short-term safety and efficacy of combining cryoballoon ablation (CBA) with LAAC in paroxysmal (PAF) patients. Method and Results. From Jan 2016 to Dec 2024, 304 patients diagnosed with nonvalvular, drug-refractory PAF were included, who underwent either CBA alone (n = 262) or combined procedure …
Pulmonary vein isolation cryoablation for patients with persistent …
WebMay 18, 2024 · This study sought to characterize the performance of the updated DTA system for the treatment of patients with drug-refractory paroxysmal and persistent AF (PAF and PsAF). The primary effectiveness endpoint was freedom from atrial arrhythmia recurrence following a 90-day blanking period through 12 months, and the primary safety … WebAug 29, 2024 · The United States Food and Drug Administration (FDA) recently expanded the indication for Medtronic cryoablation therapy to include treating patients with symptomatic, recurrent persistent AF, in ... email to send an invoice
Catheter Ablation for Paroxysmal Atrial Fibrillation
WebAug 1, 2024 · Subjects were age 18 to 85 years and undergoing a planned ablation procedure for symptomatic drug-refractory PAF. Subjects had to have at least 1 failed Class I or III AAD and at least 1 episode of PAF documented within 6 months before enrollment. ... In patients with drug-refractory symptomatic paroxysmal atrial fibrillation, … WebDec 1, 2001 · A combined analysis of available trials reported that amiodarone was effective in 60–70% of patients with drug‐refractory AF. 51, 64 However, there has been a lack of prospective data on the role of amiodarone as the first‐line treatment of patients with recurrence of AF, until the recent Canadian Trial of Atrial Fibrillation (CTAF) study ... WebMar 17, 2024 · These studies have consistently demonstrated that CA is superior to AADs for the reduction of AA recurrence and the avoidance of AF disease progression. 16–19 Accordingly, the use of CA has received a Class I recommendation in patients with symptomatic, drug-refractory PAF in current guidelines. 1 However, the safety and … ford series 105a used parts